Given our experience with site-specific labelling by glycan modification [18], 6E11 was conjugated site-specifically and evaluated in NSCLC xenografts and syngeneic mouse tumour models with varying PD-L1 expression. Here, CD274 is linked to non-small cell lung carcinoma.